XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Net Income
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Distributions
Beginning balance (in shares) at Dec. 31, 2022     14,709,000        
Beginning balance at Dec. 31, 2022 $ 271,579 $ (6,595) $ 15 $ 238,505 $ 52,290 $ (6,595) $ (19,231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants 121     121      
Share repurchases (in shares)     (1,000)        
Share repurchases (13)     (13)      
Share forfeitures (in shares)     (1,000)        
Share forfeitures (1)     (1)      
Net income 7,803       7,803    
Distributions (5,147)           (5,147)
Ending balance (in shares) at Mar. 31, 2023     14,707,000        
Ending balance at Mar. 31, 2023 $ 267,747   $ 15 238,612 53,498   (24,378)
Beginning balance (in shares) at Dec. 31, 2023 14,811,410   14,811,000        
Beginning balance at Dec. 31, 2023 $ 271,248   $ 15 239,443 71,660   (39,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants $ 336     336      
Share repurchases (in shares) (5,916)   (6,000)        
Share repurchases $ (75)     (75)      
Net income 5,233       5,233    
Distributions $ (5,184)           (5,184)
Ending balance (in shares) at Mar. 31, 2024 14,805,494   14,805,000        
Ending balance at Mar. 31, 2024 $ 271,558   $ 15 $ 239,704 $ 76,893   $ (45,054)